Consequently, we conducted a two-stage study to systematically describe the BRCA1/2 spectra of Chinese women by direct sequencing in familial breast cancer patients and validated the candidate variants in multicancer-type samples. The gene discussed is BRCA1; the disease is breast carcinoma.